✦ LIBER ✦

Reply to the letter by Chatterjee et al “Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial”

✍ Scribed by Jeffery S. Berger; Deepak L. Bhatt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding, mortality, and antiplatelet th

✍ Saurav Chatterjee; Subhankar Maitra; Anasua Chakraborty 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Bleeding, mortality, and antiplatelet th

✍ Jeffrey S. Berger; Deepak L. Bhatt; P. Gabriel Steg; Steven R. Steinhubl; Gilles 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Bleeding Complications With Dual Antipla

✍ P.B. Berger; D.L. Bhatt; V. Fuster 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Clopidogrel added to aspirin versus aspi

✍ Deepak L. Bhatt; Eric J. Topol 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Clinical Outcomes of Patients With Diabe

✍ Arijit Dasgupta; Steven R. Steinhubl; Deepak L. Bhatt; Peter B. Berger; Mingyuan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 369 KB